Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:768-776
Published online before print August 23, 2007, doi: 10.1161/CIRCRESAHA.106.146159
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/8/768    most recent
CIRCRESAHA.106.146159v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Netherton, S. J.
Right arrow Articles by Maurice, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Netherton, S. J.
Right arrow Articles by Maurice, D. H.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Angiogenesis
Right arrow Cell biology/structural biology
Right arrow Cell signalling/signal transduction
Right arrow Metabolism
Right arrow Signal transduction
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2007;101:768.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Both Protein Kinase A and Exchange Protein Activated by cAMP Coordinate Adhesion of Human Vascular Endothelial Cells

Stuart J. Netherton*, Jayda A. Sutton*, Lindsay S. Wilson, Rhonda L. Carter, Donald H. Maurice

From the Departments of Pharmacology & Toxicology (S.J.N., J.A.S., R.L.C.) and Pathology & Molecular Medicine (L.S.W., D.H.M.), Queen’s University, Kingston, Ontario, Canada.

Correspondence to Dr D. H. Maurice, PhD, Heart and Stroke Foundation of Ontario Career Investigator, Department of Pharmacology & Toxicology, Queen’s University, Kingston, ON, Canada, K7L 3N6. E-mail mauriced{at}post.queensu.ca

cAMP regulates integrin-dependent adhesions of vascular endothelial cells (VECs) to extracellular matrix proteins, their vascular endothelial cadherin–dependent intercellular adhesions, and their proliferation and migration in response to growth and chemotactic factors. Previously, we reported that cAMP-elevating agents differentially inhibited migration of human VECs isolated from large vascular structures (macro-VECs, human aortic endothelial cells [HAECs]) or small vascular structures (micro-VECs, human microvascular endothelial cells [HMVECs]) and that cAMP hydrolysis by phosphodiesterase (PDE)3 and PDE4 enzymes was important in coordinating this difference. Here we report that 2 cAMP-effector enzymes, namely protein kinase (PK)A and exchange protein activated by cAMP (EPAC), each regulate extracellular matrix protein–based adhesions of both macro- and micro-VECs. Of interest and potential therapeutic importance, we report that although specific pharmacological activation of EPAC markedly stimulated adhesion of micro-VECs to extracellular matrix proteins when PKA was inhibited, this treatment only modestly promoted adhesion of macro-VECs. Consistent with an important role for cAMP PDEs in this difference, PDE3 or PDE4 inhibitors promoted EPAC-dependent adhesions in micro-VECs when PKA was inhibited but not in macro-VECs. At a molecular level, we identify multiple, nonoverlapping, PKA- or EPAC-based signaling protein complexes in both macro- and micro-VECs and demonstrate that each of these complexes contains either PDE3B or PDE4D but not both of these PDEs. Taken together, our data support the concept that adhesion of macro- and micro-VECs is differentially regulated by cAMP and that these differences are coordinated through selective actions of cAMP at multiple nonoverlapping signaling complexes that contain PKA or EPAC and distinct PDE variants.


Key Words: endothelium • adhesion • PKA • EPAC • phosphodiesterase




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Torella, C. Gasparri, G. M. Ellison, A. Curcio, A. Leone, C. Vicinanza, V. Galuppo, I. Mendicino, W. Sacco, I. Aquila, et al.
Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP/PKA-activated p85{alpha}PI3K
Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2015 - H2025.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. R. Raymond, R. L. Carter, C. A. Ward, and D. H. Maurice
Distinct phosphodiesterase-4D variants integrate into protein kinase A-based signaling complexes in cardiac and vascular myocytes
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H263 - H271.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. S. Wilson, H. S. Elbatarny, S. W. Crawley, B. M. Bennett, and D. H. Maurice
Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions
PNAS, September 9, 2008; 105(36): 13650 - 13655.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. E. Goldfinger, E. Tzima, R. Stockton, W. B. Kiosses, K. Kinbara, E. Tkachenko, E. Gutierrez, A. Groisman, P. Nguyen, S. Chien, et al.
Localized {alpha}4 Integrin Phosphorylation Directs Shear Stress-Induced Endothelial Cell Alignment
Circ. Res., July 18, 2008; 103(2): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Hao, Y. Huang, J. Cleman, I. S. Jovin, W. W. Vale, T. L. Bale, and F. J. Giordano
Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation
PNAS, March 11, 2008; 105(10): 3939 - 3944.
[Abstract] [Full Text] [PDF]